We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Elaine Hylek

Elaine M Hylek MD, MPH

Professor of Medicine at Boston University School of Medicine, Boston, MA

Elaine M. Hylek, MD, MPH, is a Professor of Medicine at Boston University School of Medicine. She received her MD from the University of Pittsburgh School Of Medicine and a Masters in Public Health (quantitative methods) from Harvard University School of Public Health. She completed her residency training in internal medicine at Massachusetts General Hospital and Harvard Medical School in Boston, Massachusetts. Her research areas include arterial (stroke) and venous thrombosis, anticoagulant therapies, and atrial fibrillation. She has served as PI on several NIH R01 grants, served on the Executive Steering Committees for international clinical trials and national registries, Event Adjudication Committees, and Data Safety Monitoring Boards. She has also served as the Late Breaking Clinical Trial Discussant for multiple international trials in the field of thrombosis. Dr. Hylek is a Section Editor for Thrombosis and Haemostasis, a member of the International Society of Thrombosis and Haemostasis Executive Committee for World Thrombosis Day, and the Director of the Thrombosis and Anticoagulation Service at Boston Medical Center. She is extensively published and designated a U.S. News Top Doctor and voted Best Doctors in America for the past decade.

Disclosures

Dr. Hylek's Disclosures:

  • Consultant: Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Medtronic, Myokardia, Pfizer
  • Research: Abbott, Janssen